Home > Insider Trading > Filing (0001209191-19-054999)

Filing Details

Accession Number:: 0001209191-19-054999
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-11-04 17:43:40
Reporting Period:: 2019-11-04

Accepted Time:: 2019-11-04 17:43:40
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1673772	Rapt Therapeutics Inc.	RAPT	()	DE

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1600420	Column Group Ii, Lp	1700 Owens Street Suite 500 San Francisco CA 94158	No	No	Yes	No
1606074	Peter Svennilson	1700 Owens Street Suite 500 San Francisco CA 94158	No	No	Yes	Yes
1614186	Tim Kutzkey	1700 Owens Street Suite 500 San Francisco CA 94158	No	No	Yes	Yes
1645333	Column Group Ii Gp, Lp	1700 Owens Street Suite 500 San Francisco CA 94158	No	No	Yes	Yes
1707230	Ponoi Capital, Lp	1700 Owens Street Suite 500 San Francisco CA 94158	No	No	Yes	No
1720702	Ponoi Management, Llc	1700 Owens Street Suite 500 San Francisco CA 94158	No	No	Yes	Yes
1732601	Ponoi Capital Ii, Lp	1700 Owens Street Suite 500 San Francisco CA 94158	No	No	Yes	No
1746488	Ponoi Ii Management, Llc	1700 Owens Street Suite 500 San Francisco CA 94158	No	No	Yes	Yes
1783952	Column Group Ii Management, Lp	1700 Owens Street, Suite 500 San Francisco CA 94158	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-11-04	2,463,659	$0.00	2,463,659	No	4	C	Direct
Common Stock	Acquisiton	2019-11-04	1,166,666	$0.00	3,630,325	No	4	C	Direct
Common Stock	Acquisiton	2019-11-04	727,008	$0.00	4,357,333	No	4	C	Direct
Common Stock	Acquisiton	2019-11-04	625,000	$12.00	4,982,333	No	4	P	Direct
Common Stock	Acquisiton	2019-11-04	1,454,016	$0.00	1,454,016	No	4	C	Direct
Common Stock	Acquisiton	2019-11-04	145,401	$0.00	1,599,417	No	4	C	Direct
Common Stock	Acquisiton	2019-11-04	145,401	$0.00	145,401	No	4	C	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct
No	4	P	Direct
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2019-11-04	14,781,963	$0.00	2,463,659	$0.00
Common Stock	Series B Preferred Stock	Disposition	2019-11-04	7,000,000	$0.00	1,166,666	$0.00
Common Stock	Series C Preferred Stock	Disposition	2019-11-04	4,362,050	$0.00	727,008	$0.00
Common Stock	Series C Preferred Stock	Disposition	2019-11-04	8,724,100	$0.00	1,454,016	$0.00
Common Stock	Series C-2 Preferred Stock	Disposition	2019-11-04	872,410	$0.00	145,401	$0.00
Common Stock	Series C-2 Preferred Stock	Disposition	2019-11-04	872,410	$0.00	145,401	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	50,000	Direct

Footnotes

At the closing of the Issuer's initial public offering, each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock,and Series C-2 Preferred Stock of the Issuer automatically converted into approximately 0.166 shares of the Issuer's common stock (on an adjusted basis, after giving effect to the 1-for-6 reverse stock split of the common stock effected by the Issuer on July 19, 2019) for no additional consideration. Shares of Series B Preferred Stock have no expiration date.
The securities are directly held by The Column Group II, LP ("TCG II LP") and indirectly held by The Column Group II GP, LP ("TCG II GP"), the general partner of TCG II LP. The managing partners of TCG II GP are David Goeddel and Peter Svennilson. The managing partners of TCG II GP may be deemed to have voting and investment power with respect to such shares. Each individual managing partner disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares.
The securities are directly held by Ponoi Capital, LP ("Ponoi LP") and indirectly held by Ponoi Management, LLC ("Ponoi LLC"), the general partner of Ponoi LP. The managing partners of Ponoi LLC are David Goeddel, Peter Svennilson and Tim Kutzkey. The managing partners of Ponoi LLC may be deemed to have voting and investment power with respect to such shares. Each individual managing partner disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares.
The securities are directly held by Ponoi Capital II, LP ("Ponoi II LP") and indirectly held by Ponoi II Management, LLC ("Ponoi II LLC"), the general partner of Ponoi II LP. The managing partners of Ponoi II LLC are David Goeddel, Peter Svennilson and Tim Kutzkey. The managing partners of Ponoi II LLC may be deemed to have voting and investment power with respect to such shares. Each individual managing partner disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares.
The securities are directly held by The Column Group II Management, LP ("TCGM II LP"). The managing partners of TCGM II LP are David Goeddel and Peter Svennilson. The managing partners of TCGM II LP may be deemed to have voting and investment power with respect to such shares. Each individual managing partner disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares.